Wells Fargo analyst Mike Mayo maintained a Sell rating on MorganStanley (MS – Research Report) today and set a price target of $95.00. The company’s shares closed yesterday at $102.34. Mayo ...
Estrella Immunopharma said the first patient in a clinical trial had a complete response to a T-cell therapy for lymphoma. The biopharmaceutical company said the patient, diagnosed with follicular ...